Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next

The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and commercialization in global markets excluding China, Hong Kong, Taiwan, Macau, and Republic of Korea Samsung Bioepis continues to pave the way for access to life-changing medicines by advancing a biosimilar pipeline across immunology and oncology […]


17 h.
Technology
ID: -7860205254752091553


Similar News expand_more


Technology
Economics
Economics
Economics
Technology
Science
Technology
Technology
Technology
Economics
Science
Technology
Technology
Technology
Technology
Economics
Science
Technology
Technology
Technology
Economics
Technology
Economics
Economics
Technology
Technology
Technology
Technology
Science
Technology
Technology
Economics
Education
Technology
Technology
Technology
Technology
Technology
Economics
Real Estate
Economics
Economics
Technology
Technology
Economics
Technology
Technology
Sport
Sport
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down